Trial
NCT02442492
Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of British Columbia
Collaborators
—
Condition
Intrauterine Growth Restriction (IUGR)
Intervention
Sildenafil
Why stopped
Trial terminated following Dutch DSMB recommendation for their Study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-11